内皮素受体拮抗剂，已知对健康有益，但具体机制不明确。
Endothelin receptor antagonists are known to have health benefit but precisely why was an unknown, said Pollock, corresponding author on the study.
内皮素受体拮抗剂波生坦是治疗肺动脉高压的有效药物之一。
The endothelin receptor antagonist bosentan is one of the effective drugs for pulmonary arterial hypertension.
结论内皮素受体拮抗剂BQ - 123对缺血性急性肾功能衰竭早期之肾脏具有一定的保护作用。
Conclusion the endothelin receptor antagonist BQ 123 does provide a certain degree of protection for kidneys from the early stage of IARF.
瑞士最大的生物科技公司Actelion股价下跌8.6%，此前该公司生产的内皮素受体拮抗剂克拉生坦没有达到研发的主要目标。
Actelion Ltd., the largest Swiss biotechnology company, sank 8.6 percent after its clazosentan medicine didn’t meet the main goal of a study.
西他生坦服用者中出现不可逆转的肝功能衰竭及其在全球市场的召回事件，强调了对服用内皮素受体拮抗剂的患者进行肝功能监测的重要性。
The irreversible liver failure caused by sitaxsentan and its withdrawal from global markets emphasise the importance of hepatic monitoring in patients treated with endothelin receptor antagonists.
目前已知一类称为内皮素受体A拮抗剂的药物能减少蛋白尿。
It's also known that a new class of drugs called endothelin a receptor antagonists reduce protein in the urine.
目的：研究不同剂量内皮素受体A拮抗剂FR139317对大鼠心力衰竭模型的作用。
AIM: To study the effects of a selective endothelin receptor A (ETA) antagonist FR139317 on rats with congestive heart failure.
目的：研究不同剂量内皮素受体A拮抗剂FR139317对大鼠心力衰竭模型的作用。
AIM: To study the effects of a selective endothelin receptor A (ETA) antagonist FR139317 on rats with congestive heart failure.
应用推荐